Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
25/05/2021 - 6 minutes
Genmab
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
27/04/2021 - 6 minutes
The 21 European Biotech Companies to Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
11/01/2021 - 11 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal
AbbVie and Genmab have announced a €3.4B collaboration deal that ranks as the second biggest…
11/06/2020 - 3 minutes
European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm
Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis…
17/09/2019 - 4 minutes
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M…
18/07/2019 - 2 minutes
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could…
11/06/2019 - 2 minutes
The 8 Best Biotech Companies in Europe’s History
We’ve put together a list of the best biotech companies in Europe to celebrate their…
02/04/2019 - 8 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Multiple Myeloma Antibody Therapy Achieves Positive Phase III Results
An antibody therapy for the blood cancer multiple myeloma achieved positive results at Phase III,…
31/10/2018 - 2 minutes
